Company presentations
Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate.
May 6, 16:00 - 16:15, room Singapore
Name | Position | Institution |
---|---|---|
Tim Dyer | CEO |